MyFinsight
Home
Blog
About
Back
Income Statement
ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals, Inc. (SPRY)
source: myfinsight.com
Comprehensive loss
-$62,383K
(-38.63%↓ Y/Y)
Net loss
-$62,339K
(-38.89%↓ Y/Y)
Unrealized gaines on
available-for-sale securities
-$44K
(62.71%↑ Y/Y)
Product
$26,210K
(104.77%↑ Y/Y)
Revenue Under Supply
Agreements
$7,391K
(2188.24%↑ Y/Y)
Revenue Under
Collaboration Agreements
$57K
(-97.80%↓ Y/Y)
Loss from operations
-$61,465K
(-29.09%↓ Y/Y)
Total other (expense)
income, net
-$874K
(-132.00%↓ Y/Y)
Total revenue
$33,658K
(114.15%↑ Y/Y)
Interest income
$1,605K
Total operating
expenses
$95,123K
(50.20%↑ Y/Y)
Interest expense
(including related party...
$2,479K
Selling, general and
administrative (including...
$77,579K
(42.84%↑ Y/Y)
Cost of goods sold
(including related party...
$12,846K
(157.74%↑ Y/Y)
Research and development
(including related party...
$4,698K
(16.43%↑ Y/Y)
Back